Publikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (33)

2021

  1. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

2015

  1. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 97, pp. 280-289

  2. Zein nanoparticles for oral folic acid delivery

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 450-457

2012

  1. Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles

    Journal of Controlled Release, Vol. 162, Núm. 3, pp. 553-560

  2. Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery

    Pharmaceutical Research, Vol. 29, Núm. 9, pp. 2615-2627

2011

  1. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

2009

  1. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne

    Journal of Immunological Methods, Vol. 348, Núm. 1-2, pp. 1-8

  2. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 231-240

2008

  1. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 3, pp. 711-717

2007

  1. An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 44, Núm. 5, pp. 1072-1078

  2. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles

    Vaccine, Vol. 25, Núm. 48, pp. 8123-8132

  3. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens

    Vaccine, Vol. 25, Núm. 29, pp. 5263-5271

  4. Intradermal immunization with ovalbumin-loaded poly-ε-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

    Clinical and Experimental Allergy, Vol. 37, Núm. 2, pp. 287-295

2006

  1. Bioadhesive mannosylated nanoparticles for oral drug delivery

    Journal of Nanoscience and Nanotechnology

  2. Chemical and biological factors in the control of Brucella and brucellosis

    Current Drug Delivery, Vol. 3, Núm. 4, pp. 359-365

  3. Development of a novel vaccine delivery system based on gantrez nanoparticles

    Journal of Nanoscience and Nanotechnology

2005

  1. Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

    Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 3, pp. 293-305

  2. Bioadhesive properties of pegylated nanoparticles

    Expert Opinion on Drug Delivery, Vol. 2, Núm. 2, pp. 205-218

  3. Encapsulation of ganciclovir in albumin nanoparticles enhances the thymidine kinase suicide gene therapy

    Journal of Drug Delivery Science and Technology, Vol. 15, Núm. 2, pp. 121-127

  4. Salmonella-like bioadhesive nanoparticles

    Journal of Controlled Release, Vol. 106, Núm. 1-2, pp. 1-13